Team:MIT/Medals
From 2014.igem.org
(Difference between revisions)
Line 52: | Line 52: | ||
<br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective, and most publicly acceptable method of delivery would be used. | <br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective, and most publicly acceptable method of delivery would be used. | ||
<br> We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our <a href="https://2014.igem.org/Team:MIT/Outreach" style="color:teal"> Outreach</a> page for more details). Armed with the industry opinion and our own research, we designed various methods of delivery and considered the pros and cons of each. | <br> We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our <a href="https://2014.igem.org/Team:MIT/Outreach" style="color:teal"> Outreach</a> page for more details). Armed with the industry opinion and our own research, we designed various methods of delivery and considered the pros and cons of each. | ||
- | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our <a href="https://2014.igem.org/Team:MIT/ | + | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our <a href="https://2014.igem.org/Wiki/2014.igem.org/Team:MIT/Survey" style="color:teal"> public opinion survey</a>. |
<br> Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but also explored numerous other delivery options.</dd></dl></li> | <br> Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but also explored numerous other delivery options.</dd></dl></li> | ||
</ol> | </ol> |
Revision as of 01:54, 18 October 2014
Home | Our Project | Lab Work | Outreach | About Us | Medals |
MEDALS | |
Attributions: Alexa Garcia, Christian Richardson | |
Gold Medal | |
| |
Silver Medal | |
| |
Bronze Medal | |
| |